The Respiratory Drug Delivery (RDD) 2020 Conference provides a great platform for discussions of advances in respiratory drug delivery science. Join the conversation on pulmonary and nasal formulation challenges together with the delegates from biopharma companies, drug delivery and formulation service providers, consultants, academia and the regulatory field.
For detailed information, visit RDD website.
Meet with us to discuss our latest service offering for optimizing DPI formulations leveraging extensive particle engineering expertise in both particle size reduction and spray drying technologies.
Sizing up capsule-based inhalers for delivery of higher drug loadings
SESSION 4: Platinum Sponsor Seminars
Tuesday, April 28, 2020. 8:00 am - 9:30 am
Presenter: Herbert Chiou PhD, DPI Product Development Lead at Lonza
About: Challenges for scaling up capsule-based DPI formulations with respect to both capsule and inhaler are discussed, based on the study of aerosol performance of a model compound in both micronized and spray dried forms.
Additional information on Lonza's services covering particle engineering for respiratory applications, DPI formulation development and encapsulation is discussed in our Webinar “Technical considerations for capsule-based inhalation product development” airing April 7, 2020. In this webinar, Lonza scientists will discuss the interplay between the DPI formulation, capsule and device, and the role of particle engineering using jet milling and spray drying approaches.
Can't join the webinar or RDD presentation?
Use the form below to schedule a meeting with Lonza during BioPharma Development and Production week.